Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Opvero (tOPV) in Children and Infants in the Dominican Republic
NCT02580201Phase 4Completed
- Sponsor
- Fighting Infectious Diseases in Emerging Countries
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 4 trial of bivalent oral poliovirus vaccine in poliomyelitis, sponsored by Fighting Infectious Diseases in Emerging Countries. Started Nov 2015; status: completed.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02580201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580201.